A Systematic Review of Cost-Effectiveness Analyses for Hepatocellular Carcinoma Treatment.
Sydney C YuenAdaeze Q AmaefuleHannah H KimBreanna-Verissa OwooEmily F GormanJoseph T MattinglyPublished in: PharmacoEconomics - open (2021)
The majority of HCC treatments were found to be cost effective, but with significant variation and with few studies considering indirect costs. Standards for value assessment for HCC treatments may help improve consistency and comparability.
Keyphrases